Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
2.850
-0.090 (-3.06%)
Jun 5, 2025, 4:00 PM - Market closed

Alpha Tau Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Selling, General & Admin
9.189.029.2611.252.341.7
Upgrade
Research & Development
27.7427.0226.4220.8911.457.54
Upgrade
Operating Expenses
36.9336.0435.6832.1413.799.24
Upgrade
Operating Income
-36.93-36.04-35.68-32.14-13.79-9.24
Upgrade
Interest Expense
-0.3-0.3-0.08---
Upgrade
Interest & Investment Income
4.554.284.831.790.210.61
Upgrade
Currency Exchange Gain (Loss)
0.110.11-0.210.41-0.410.1
Upgrade
Other Non Operating Income (Expenses)
0.220.221.99-3.81-13.27-0.19
Upgrade
Pretax Income
-32.36-31.74-29.14-33.74-27.26-8.72
Upgrade
Income Tax Expense
0.10.010.020.020.010.16
Upgrade
Earnings From Continuing Operations
-32.46-31.75-29.16-33.76-27.27-8.88
Upgrade
Net Income
-32.46-31.75-29.16-33.76-27.27-8.88
Upgrade
Net Income to Common
-32.46-31.75-29.16-33.76-27.27-8.88
Upgrade
Shares Outstanding (Basic)
707069644140
Upgrade
Shares Outstanding (Diluted)
707069644140
Upgrade
Shares Change (YoY)
0.87%0.79%9.20%56.74%0.65%19.10%
Upgrade
EPS (Basic)
-0.46-0.45-0.42-0.53-0.67-0.22
Upgrade
EPS (Diluted)
-0.46-0.45-0.42-0.53-0.67-0.22
Upgrade
Free Cash Flow
--22.02-24.36-24.78-14.74-11.02
Upgrade
Free Cash Flow Per Share
--0.32-0.35-0.39-0.36-0.27
Upgrade
EBITDA
-35.82-34.94-34.61-31.16-13.01-9.16
Upgrade
D&A For EBITDA
1.111.11.070.980.780.09
Upgrade
EBIT
-36.93-36.04-35.68-32.14-13.79-9.24
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q